156 related articles for article (PubMed ID: 9666515)
1. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide.
Taimi M; Chen ZX; Breitman TR
Oncol Res; 1998; 10(2):75-84. PubMed ID: 9666515
[TBL] [Abstract][Full Text] [Related]
2. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
Breitman TR; He RY
Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
[TBL] [Abstract][Full Text] [Related]
3. Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells.
Chen Z; Wang W; Pan J; Chen L; Xue Y
Chin Med J (Engl); 1999 Apr; 112(4):352-5. PubMed ID: 11593538
[TBL] [Abstract][Full Text] [Related]
4. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen ZX; Breitman TR
Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
[TBL] [Abstract][Full Text] [Related]
5. N-4-hydroxyphenylretinamide enhances retinoic acid-induced differentiation and retinoylation of proteins in the human acute promyelocytic leukemia cell line, NB4, by a mechanism that may involve inhibition of retinoic acid catabolism.
Taimi M; Breitman TR
Biochem Biophys Res Commun; 1997 Mar; 232(2):432-6. PubMed ID: 9125196
[TBL] [Abstract][Full Text] [Related]
6. Potential applications of cytodifferentiation therapy in hematologic malignancies.
Breitman TR; Chen ZX; Takahashi N
Semin Hematol; 1994 Oct; 31(4 Suppl 5):18-25. PubMed ID: 7831581
[TBL] [Abstract][Full Text] [Related]
7. Effects of prostaglandin E2 and all-trans retinoic acid combination on induced differentiation of human acute promyelocytic leukemia NB4 cells.
Chen Z; Breitman TR
Chin Med J (Engl); 1997 Oct; 110(10):783-8. PubMed ID: 9642310
[TBL] [Abstract][Full Text] [Related]
8. A retinoid/butyric acid prodrug overcomes retinoic acid resistance in leukemias by induction of apoptosis.
Mann KK; Rephaeli A; Colosimo AL; Diaz Z; Nudelman A; Levovich I; Jing Y; Waxman S; Miller WH
Mol Cancer Res; 2003 Oct; 1(12):903-12. PubMed ID: 14573791
[TBL] [Abstract][Full Text] [Related]
9. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
10. 4-Oxoretinol, a metabolite of retinol in the human promyelocytic leukemia cell line NB4, induces cell growth arrest and granulocytic differentiation.
Faria TN; Rivi R; Derguini F; Pandolfi PP; Gudas LJ
Cancer Res; 1998 May; 58(9):2007-13. PubMed ID: 9581846
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid resistance in NB4 APL cells is associated with lack of interferon alpha synthesis Stat1 and p48 induction.
Pelicano L; Brumpt C; Pitha PM; Chelbi-Alix MK
Oncogene; 1999 Jul; 18(27):3944-53. PubMed ID: 10435617
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid is required for and potentiates differentiation of acute promyelocytic leukemia cells by nonretinoid agents.
Chen A; Licht JD; Wu Y; Hellinger N; Scher W; Waxman S
Blood; 1994 Oct; 84(7):2122-9. PubMed ID: 7919325
[TBL] [Abstract][Full Text] [Related]
13. Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
Snyder SW; Egorin MJ; Geelhaar LA; Hamburger AW; Callery PS
Cancer Res; 1988 Jul; 48(13):3613-6. PubMed ID: 3163938
[TBL] [Abstract][Full Text] [Related]
14. Growth, differentiation, and death of retinoic acid-treated human acute promyelocytic leukemia NB4 cells.
Taimi M; Breitman TR
Exp Cell Res; 1997 Jan; 230(1):69-75. PubMed ID: 9013708
[TBL] [Abstract][Full Text] [Related]
15. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells.
Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE
Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735
[TBL] [Abstract][Full Text] [Related]
16. Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled.
Bastie JN; Balitrand N; Guillemot I; Chomienne C; Delva L
Exp Cell Res; 2005 Nov; 310(2):319-30. PubMed ID: 16181625
[TBL] [Abstract][Full Text] [Related]
17. A novel retinoic/butyric hyaluronan ester for the treatment of acute promyelocytic leukemia: preliminary preclinical results.
Coradini D; Pellizzaro C; Scarlata I; Zorzet S; Garrovo C; Abolafio G; Speranza A; Fedeli M; Cantoni S; Sava G; Daidone MG; Perbellini A
Leukemia; 2006 May; 20(5):785-92. PubMed ID: 16525489
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells.
Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH
Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820
[TBL] [Abstract][Full Text] [Related]
19. [Study on the differentiation and apoptosis of promyelocytic leukemia cells induced by tributyrin].
Qiu H; Wang W; Cen J; Pan J; Wang Y; Fu J; Chen Z
Zhonghua Xue Ye Xue Za Zhi; 2000 Feb; 21(2):77-80. PubMed ID: 11876963
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia.
Muindi JR; Frankel SR; Huselton C; DeGrazia F; Garland WA; Young CW; Warrell RP
Cancer Res; 1992 Apr; 52(8):2138-42. PubMed ID: 1559217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
